Fox Run Management L.L.C. Takes Position in Henry Schein, Inc. (NASDAQ:HSIC)

Fox Run Management L.L.C. acquired a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 11,764 shares of the company's stock, valued at approximately $814,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Pathstone Holdings LLC raised its holdings in Henry Schein by 3.1% during the third quarter. Pathstone Holdings LLC now owns 24,028 shares of the company's stock valued at $1,752,000 after buying an additional 732 shares in the last quarter. B. Metzler seel. Sohn & Co. Holding AG bought a new stake in shares of Henry Schein during the 3rd quarter worth $515,000. PNC Financial Services Group Inc. grew its stake in Henry Schein by 2.8% in the 3rd quarter. PNC Financial Services Group Inc. now owns 86,143 shares of the company's stock valued at $6,280,000 after buying an additional 2,380 shares during the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. raised its holdings in Henry Schein by 5.9% in the 3rd quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 122,721 shares of the company's stock worth $8,946,000 after acquiring an additional 6,826 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its position in Henry Schein by 0.5% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,175,061 shares of the company's stock worth $85,662,000 after acquiring an additional 6,184 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.

Insiders Place Their Bets

In related news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the transaction, the chief executive officer now directly owns 62,688 shares in the company, valued at $4,460,251.20. This represents a 6.05 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of the firm's stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the transaction, the director now owns 24,805 shares in the company, valued at $1,762,147.20. This represents a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.14% of the company's stock.

Remove Ads

Henry Schein Price Performance

Shares of HSIC stock traded down $0.78 during trading hours on Friday, hitting $68.62. 1,028,798 shares of the company's stock were exchanged, compared to its average volume of 1,573,330. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.49. The stock has a market cap of $8.52 billion, a price-to-earnings ratio of 28.24, a price-to-earnings-growth ratio of 2.13 and a beta of 0.90. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The stock's 50-day moving average is $74.62 and its 200-day moving average is $72.60.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. During the same period in the prior year, the company earned $0.66 EPS. The firm's revenue was up 5.8% compared to the same quarter last year. As a group, research analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current year.

Analyst Ratings Changes

HSIC has been the subject of several recent analyst reports. Jefferies Financial Group increased their target price on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research note on Thursday, January 23rd. Barrington Research reissued an "outperform" rating and issued a $90.00 target price on shares of Henry Schein in a research note on Wednesday, February 26th. Mizuho began coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They set a "neutral" rating and a $75.00 price target for the company. Wells Fargo & Company started coverage on Henry Schein in a research note on Friday, February 14th. They issued an "equal weight" rating and a $80.00 price objective on the stock. Finally, UBS Group cut their target price on Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research report on Wednesday, February 26th. Six research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Henry Schein presently has an average rating of "Moderate Buy" and a consensus price target of $81.10.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.